Durvalumab Receives Orphan Drug Designation for Small Cell Lung Cancer
The FDA has granted Orphan Drug designation to Imfinzi for the treatment of small cell lung cancer.
Lung Cancer
Increasing USPSTF Lung Cancer Screening Eligibility in African American Smokers
Lowering the USPSTF smoking pack-year lung cancer screening criteria to a minimum 20-pack-year history may increase the number of African American smokers who are screened.
NLST Extended Follow-Up Supports Low-Dose CT for Lung Cancer Screening
Researchers found 1701 and 1681 lung cancers were diagnosed in the low-dose computed tomography and chest radiograph arms, respectively.
Image-Based Model Predicts Radiation Treatment Failure in Lung Cancer
Higher rate of treatment failure in patients with lung cancer who had high Deep Profiler scores.
Clinical Implications of Nonexpandable Lung in Mesothelioma
The presence of nonexpandable lung can be an independent predictor of mortality in mesothelioma.
Model Can Predict Lung Cancer in Patients With Visible Nodule on CT
A combination of clinical and radiologic factors can reliably predict risk for incident lung cancer.
NSCLC Survival Improved by Adding Bevacizumab
Addition of bevacizumab to carboplatin/pemetrexed was beneficial in advanced non-small cell lung cancer.
Pembrolizumab Approved to Treat Metastatic Small Cell Lung Cancer
The approval was based on data from 83 patients with SCLC who were enrolled in either the KEYNOTE-028 or KEYNOTE-158 trials.
Number of Cancer Survivors Set to Surpass 22 Million by 2030
More than 50% of cancer survivors were diagnosed within past 10 years.
Cardiac Radiation Dose in NSCLC Predicts Mortality, Cardiac Adverse Events
In coronary heart disease-negative patients, the mean heart dose (≥10 Gy vs <10 Gy) was associated with a significantly increased risk for all-cause mortality.
Next post in Lung Cancer
